IGC Pharma
IGC
#10740
Rank
C$29.31 M
Marketcap
C$0.25
Share price
-4.61%
Change (1 day)
-47.31%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -C$9.05 Million

According to IGC Pharma's latest financial reports the company's current earnings are C$1.18 Million. In 2025 the company made an earning of -C$7.63 Million, an increase over its 2024 earnings that were of -C$12.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$9.05 Million18.59%
2025 -C$7.63 Million-39.35%
2024 -C$12.58 Million-37.72%
2023 -C$20.2 Million1.19%
2022 -C$19.96 Million21.96%
2021 -C$16.37 Million27.13%
2020 -C$12.87 Million57.16%
2019 -C$8.19 Million85.47%
2018 -C$4.42 Million52.76%
2017 -C$2.9 Million-16.23%
2016 -C$3.46 Million-28.75%
2015 -C$4.85 Million-19.59%
2014 -C$6.03 Million6.79%
2013 -C$5.64 Million-9.47%
2012 -C$6.23 Million-74.03%
2011 -C$23.99 Million119.78%
2010 -C$10.92 Million62.02%
2009 -C$6.74 Million74.39%
2008 -C$3.87 Million-313.12%
2007 C$1.81 M-35.94%
2006 C$2.82 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
C$1.11 B-12,021.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
C$1.04 B-11,253.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-C$0.21 Billion 2,142.84%๐Ÿ‡บ๐Ÿ‡ธ USA